Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 06 Nov 2024

Tinosporae Radix attenuates acute pharyngitis by regulating glycerophospholipid metabolism and inflammatory responses through PI3K-Akt signaling pathway

in Pharmacology of Anti-Cancer Drugs

Lijie Lu
Chengfeng Huang
Yongfeng Zhou
Huajuan Jiang
Cuiping Chen
Jinyu Du
Tao Zhou
Feiyan Wen
Jin Pei
Qinghua Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491321

1,714 views

Review

Published on 05 Nov 2024

PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond

in Pharmacology of Anti-Cancer Drugs

Sameh Saber
Rasha Abdelhady
Mai A. Elhemely
Elsayed A. Elmorsy
Rabab S. Hamad
Mustafa Ahmed Abdel-Reheim
Attalla F. El-kott
Mohammed A. AlShehri
Kareem Morsy
Ali S. AlSheri

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475998

2,420 views
2 citations

Systematic Review

Published on 05 Nov 2024

Systematic review of Buzhong Yiqi method in alleviating cancer-related fatigue: a meta-analysis and exploratory network pharmacology approach

in Pharmacology of Anti-Cancer Drugs

Ji Zeng
Qi Wu
Xu-Dong Meng
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451773

2,258 views
1 citation

Review

Published on 05 Nov 2024

Emerging strategies to overcome ovarian cancer: advances in immunotherapy

in Pharmacology of Anti-Cancer Drugs

Tatiana Massariol Pimenta
Josiany Carlos de Souza
Bárbara da Silva Martins
Solenny Maria Silva Butzene
José Matheus Simões Padilha
Milleny Ganho Marçal
Guilherme dos Santos Elias
Leticia Batista Azevedo Rangel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1490896

2,027 views

Correction

Published on 04 Nov 2024

Corrigendum: Network-based prediction of anti-cancer drug combinations

in Pharmacology of Anti-Cancer Drugs

Jue Jiang
Xuxu Wei
YuKang Lu
Simin Li
Xue Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1495634

511 views

Case Report

Published on 01 Nov 2024

Case report: Treatment with ensartinib shows good response to SQSTM1-ALK fusion in lung adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Pandeng Wang
Zhuo Jiang
Jianji Guo
Tao Liu
Zhen Liu
Dongdong Wang
Honglin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433894

943 views
1 citation

Original Research

Published on 01 Nov 2024

Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers

in Pharmacology of Anti-Cancer Drugs

Jun Wu
Jinghua Lu
Qiuyue Chen
Haojie Chen
Yongqiang Zheng
Minggang Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494131

2,320 views

Original Research

Published on 01 Nov 2024

Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles

in Pharmacology of Anti-Cancer Drugs

Fei Shen
Yun-Sheng Zheng
Lan Dong
Ziyang Cao
Jie Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500731

1,658 views
2 citations

Original Research

Published on 01 Nov 2024

Transcriptome analysis revealed the genes and major pathways involved in prunetrin treated hepatocellular carcinoma cells

in Pharmacology of Anti-Cancer Drugs

Abuyaseer Abusaliya
Hun Hwan Kim
Preethi Vetrivel
Pritam Bhagwan Bhosale
Se Hyo Jeong
Min Yeong Park
Si Joon Lee
Gon Sup Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400186

922 views

Review

Published on 01 Nov 2024

Targeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy

in Pharmacology of Anti-Cancer Drugs

Qian Li
Yan Tong
Jianxiang Chen
Tian Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491802

1,364 views
1 citation

Original Research

Published on 30 Oct 2024

Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system

in Pharmacology of Anti-Cancer Drugs

Yifeng Bai
Xiaomei Wang
Xiaoqin Dai
Qinghua Ma
Honglin Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1398667

1,215 views

Review

Published on 30 Oct 2024

The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies

in Pharmacology of Anti-Cancer Drugs

Haitao Wang
Rui Tang
Ling Jiang
Yingtian Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494802

3,491 views
2 citations

Editorial

Published on 30 Oct 2024

Editorial: Novel anti-cancer agents targeting tumour metastasis and stemness

in Pharmacology of Anti-Cancer Drugs

Luping Pang
Bo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504024

783 views

Original Research

Published on 28 Oct 2024

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis

in Pharmacology of Anti-Cancer Drugs

Yuanqiong Duan
Ying Wang
Shentao Lu
Mei Zeng
Lubin Liu
Qian Dai
Rutie Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448144

1,556 views
1 citation

Review

Published on 25 Oct 2024

Anti-tumor mechanism of artesunate

in Pharmacology of Anti-Cancer Drugs

Xiaoyu Fan
Yiming Yan
Yafei Li
Yu Song
Bo Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1483049

3,374 views

Review

Published on 24 Oct 2024

Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers

in Pharmacology of Anti-Cancer Drugs

Shizong Wang
Yang Bai
Jie Ma
Liang Qiao
Mingqing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442227

1,012 views